Ventashas released its quarterly earnings results on Thursday. Ventas, listed as VTR on the New York Stock Exchange, reported $0.29 EPS for the quarter, missing the Zacks' consensus estimate of $0.73 by ($0.44). The company had posted $0.03 EPS for the same period last year.
Several stock analysts have shown interest in VTR shares. Jefferies Financial Group upgraded shares of Ventas from an "underperform" rating to a "hold" rating and set a $50.00 price objective for the company in a research note on Tuesday, November 10th.
KeyCorp raised their price target on shares of Ventas from $23.00 to $35.00 and gave the company an "underweight" rating in a report on Thursday, November 12th. Royal Bank of Canada lifted their price objective on Ventas from $45.00 to $54.00 and gave the company an "outperform" rating in a research note on Wednesday, November 11th.
Also, CEO Debra A. Cafaro sold 18,076 shares of the firm's stock in a transaction on February 1st. The stock traded at an average price of $47.05, for a total value of $850,475.80. Following the transaction, the CEO now owns 735,615 shares in the company, which is valued at $34,610,685.75. Apart from that, CFO Robert F. Probst also sold 5,500 shares of the company in November.
Ventasis an S&P 500 company, which operates under two powerful and dynamic industries - healthcare and real estate. It is a real estate investment trust specializing in the ownership and management of health care facilities in the United States, Canada, and the United Kingdom.